EX-10.1





 Exhibit 10.1 

April 12, 2021 
 John F. Thero 

 

	Re:	 Transitional Services and Separation Agreement 



Dear John: 
 This letter confirms our agreement regarding your
planned retirement and in connection therewith your resignation as President and Chief Executive Officer of Amarin Corporation plc (the “Company”). The Board of Directors of the Company (the “Board”) appreciates
your substantial contributions to the Company and would like to make this transition as seamless as possible. 
 If this Transitional Services and
Separation Agreement (this “Agreement”) becomes effective, it will fully supersede all other agreements or understandings between you and the Company relating to your employment, compensation, severance pay, benefits and equity
awards, including, without limitation (i) the employment agreement between you and the Company dated December 23, 2011, as amended on January 10, 2014 and July 6, 2015 (the “Employment Agreement”), and
(ii) the Executive Severance and Change of Control Plan dated January 28, 2021 (the “Severance Plan”); provided, however, and notwithstanding the foregoing, the Nondisclosure, Developments and Noncompetition Agreement
between you and the Company dated December 23, 2011 (the “Restrictive Covenants Agreement”), the indemnification agreement between you and the Company dated January 19, 2011 (the “Indemnification
Agreement”), and the stock option agreements in connection with each of your outstanding stock option grants as of the date hereof and the restricted stock unit award agreements in connection with each of your restricted stock unit awards
as of the date hereof (collectively, along with the Company’s equity incentive plan(s) as may be amended from time to time, the “Equity Documents”) shall remain in full force and effect both during and after your employment
with the Company, subject to this Agreement. For purposes of this Agreement, the Restrictive Covenants Agreement, the Indemnification Agreement, the Equity Documents and any other contractual obligations regarding confidentiality, invention
assignment, noncompetition or nonsolicitation, are referred to as the “Preserved Agreements.” This Agreement and the Preserved Agreements set forth all of the contractual rights and obligations between you and the Company, and you
shall not be entitled to any other payments or benefits except as specifically set forth in those documents. For the avoidance of doubt, the Company’s insider trading policy shall continue to be in effect during and after your employment,
consistent with the terms of the policy. 
 With those understandings, the Agreement between you and the Company is as follows: 

  
 1 













 1. Transition Period; CEO Retirement Date 

(a) Transition Period. If you enter into, do not revoke and comply with this Agreement, your employment with the Company will continue
until October 31, 2021 (the “Anticipated Last Day of Employment”), unless you sooner resign or the Company terminates your employment or you and the Company mutually agree in writing to extend your employment. The actual last
day of your employment is referred to herein as the “Last Day of Employment.” The time period between the date of the Company’s public announcement regarding your planned retirement and the Last Day of Employment is referred to
herein as the “Transition Period.” The Transition Period consists of two phases: Phase One and Phase Two. 
 (b) Phase
One of the Transition Period. Phase One of the Transition Period is the period between the date of the public announcement regarding your planned retirement and the CEO Retirement Date (as defined below), during which time it is anticipated that
you will continue to serve as President and CEO, work full-time, remain a member of the Board and be paid your current base salary at the rate of $844,600 per year. During Phase One of the Transition Period, you will remain eligible for employee
benefits, subject to the terms and conditions of the applicable health plan(s), and you will continue to accrue paid time off, consistent with the Company’s paid time off policy. You will also continue to vest in your outstanding stock options,
restricted stock units (“RSUs”) and restricted stock units subject to performance milestones (“PSUs”) during Phase One, subject to the terms and conditions set forth in the Equity Documents. 

(c) CEO Retirement Date. Your retirement from the role of President, CEO and a director of the Company will be effective on
August 1, 2021 (or such other date as mutually agreed by you and the Board and consistent with this Agreement, the “CEO Retirement Date”). You acknowledge and agree that your retirement from the role of President, CEO and
director and from the Company is a voluntary separation and not a termination without Cause or for Good Reason for purposes of the Employment Agreement or the Severance Plan, such that you are not eligible for any severance pay, benefits or
accelerated vesting under the Employment Agreement or the Severance Plan, which are fully superseded by this Agreement. Effective on the CEO Retirement Date, you will be deemed to have resigned as an officer and director of the Company, as well as
from any other officer or director positions that you hold with any of the Company’s subsidiaries or any affiliate of the Company. You agree to execute any documents requested by the Company or any controlled entities necessary to effectuate
such resignations. 
 (d) Phase Two of the Transition Period. Phase Two of the Transition Period is between the CEO Retirement Date
and the Last Day of Employment. During Phase Two, your position with the Company will be “Senior Advisor,” and you will work approximately 30% of a full-time executive employee. Your base salary will be reduced by 50%, such that it
will be paid at the rate of $422,300 per year during Phase Two. You will continue to be eligible for employee benefits, subject to the terms and conditions of the applicable health plan(s). You will not accrue paid time off during Phase Two. You
will also continue to vest in your outstanding stock options, RSUs and PSUs during Phase Two, subject to the terms and conditions set forth in the Equity Documents. Your employment with the Company will end at the end of Phase Two. 

  
 2 













 (e) In the event that you resign your employment or the Company terminates your employment
for Cause (as defined below), in either case prior to the Anticipated Last Day of Employment, your employment will immediately end, you will be paid your applicable base salary and any accrued but unused paid time off through the Last Day of
Employment, you will cease vesting as of the Last Day of Employment, and you shall have no right to any further compensation from the Company. For purposes of this Agreement, “Cause” has the meaning ascribed to such term in the
Employment Agreement. 
 (f) In the event that the Company terminates your employment without Cause prior to the Anticipated Last Day of
Employment, subject to you entering into general release agreement, the Company will (i) pay you the base salary that would have accrued to you if you had remained employed through the Anticipated Last Day of Employment in the form of salary
continuation on the Company’s regular payroll dates, and (ii) the portion of your stock options, RSUs and PSUs that would have vested if you had remained employed through the Anticipated Last Day of Employment will accelerate and become
fully vested and exercisable or nonforfeitable as of the Last Day of Employment. 
 2. Post-Employment Consulting 

Provided that you (i) enter into, do not revoke and comply with this Agreement, and (ii) your employment continues until the
Anticipated Last Day of Employment (the “Conditions”), then immediately following the Last Day of Employment, you will become a consultant to the Company and provide consulting services on an
as-needed basis to the Company as mutually agreed (the “Consulting Services”) until February 28, 2022 or such later date as may be agreed to in writing by you and the Board (such period,
the “Consulting Period”). For the avoidance of doubt, the Consulting Period will end on February 28, 2022 unless you and the Board agree in writing on or prior to February 28, 2022 to extend the Consulting Period. You will
be paid a consulting fee of $400 per hour during the Consulting Period. The Company will pay you such consulting fees on a monthly basis within 30 days after its receipt of an invoice detailing the number of hours and a description of the Consulting
Services performed during the applicable invoice period, as well as any other information reasonably requested by the Company. In conjunction with such Consulting Services, you will be reimbursed for all reasonable expenses you incur to perform such
Consulting Services subject to you providing documentation of such expenses and consistent with Company policy. 
 For the avoidance of
doubt, there will be no break in your service relationship with the Company between the Last Day of Employment and the first day of the Consulting Period for purposes of continued vesting in your outstanding stock options, RSUs and PSUs, which will
continue to vest during the Consulting Period, subject to the terms of the Equity Documents. 

  
 3 













 
During the Consulting Period, you will no longer be an employee of the Company, but instead will be retained as an independent contractor. You will be solely responsible for payment of all
charges and taxes arising from your relationship to the Company as an independent contractor. You agree that during the Consulting Period, you will not state or imply, directly or indirectly, that you are empowered to bind the Company without the
Company’s prior written consent. 
 3. 2021 Bonus Compensation 

Provided that you satisfy the Conditions, you will be eligible for a 2021 annual bonus, based on the achievement of the Company’s
Board-approved corporate goals as determined by the Board or the Remuneration Committee of the Board on a basis consistent with the then active officers of the Company. The bonus will be targeted at 80% of all cash compensation for 2021 as reported
to taxing authorities on Forms W-2 and 1099 minus any amount attributed to your 2020 bonus. The bonus, if any, will be paid to you if and when other executives receive their 2021 bonuses. For the avoidance of
doubt, you will not be eligible for any other incentive compensation. 
 4. Equity 

Subject to the terms set forth above and the Equity Documents, you will continue to vest in your outstanding stock options, RSUs and PSUs
during the Transition Period and the Consulting Period. Consistent with the Equity Documents, (i) your options will cease vesting (and for clarity no longer be eligible for acceleration including but not limited to in connection with a Change
of Control (as defined in the Employment Agreement)) on the last day of your service relationship with the Company as an employee or a consultant and will be exercisable until the earlier of (A)12 months following the last day your service
relationship and (B) the original 10-year expiration date for such vested options as provided in the applicable Equity Documents, and (ii) the RSUs and PSUs will lapse to the extent they are not
vested when your service relationship ends; provided, however, and notwithstanding the foregoing, that if a Change of Control occurs during the Transition Period or the Consulting Period, then all of your outstanding stock options, RSUs and PSUs
(whether or not subject to time-based vesting) shall immediately accelerate and become fully vested and exercisable or nonforfeitable as of the Date of Termination. For the avoidance of doubt, you will not be eligible for any further equity awards
during your employment or the Consulting Period. 
 5. Health Benefits 

As set forth above, you will continue to be eligible for employee health benefits during the Transition Period, subject to the terms and
conditions of the applicable health plan(s). Subject to the approval of the Company’s group health plan, you will be allowed to continue to participate in the Company’s group health plan during the Consulting Period at the group rate,
entirely at your own cost. In the event that you are not able to continue to participate in the Company’s group health plan during the Consulting Period and thereafter, you will be entitled to any rights you may have under COBRA to continuing
health care coverage, which will be entirely at your own cost. 

  
 4 













 6. Release of All Claims 

You, on your own behalf and on behalf of your heirs, executors, administrators, attorneys and assigns, hereby unconditionally and irrevocably
release, waive and forever discharge the Company and each of its affiliates, parents, successors, predecessors, and the subsidiaries, directors, owners, members, shareholders, officers, agents, and employees of the Company and its affiliates,
parents, successors, predecessors, and subsidiaries (collectively, all of the foregoing are referred to as the “Releasees”), from any and all causes of action, claims and damages, including attorneys’ fees, whether known or
unknown, foreseen or unforeseen, presently asserted or otherwise arising through the date on which you sign this Agreement. This release includes, but is not limited to, any claim or entitlement to salary, bonuses, any other payments, benefits or
damages arising under any federal law (including, but not limited to, Title VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act, the Employee Retirement Income Security Act of 1974, the Americans with Disabilities Act,
Executive Order 11246, the Family and Medical Leave Act, and the Worker Adjustment and Retraining Notification Act, each as amended and any other federal, state, local or foreign law relating to notice of employment termination or to severance pay);
any claim arising under any state or local laws, ordinances or regulations (including, but not limited to, the New Jersey Law Against Discrimination, the New Jersey Family Leave Act and any state or local laws, ordinances or regulations requiring
that advance notice be given of certain workforce reductions); any claim arising under Irish law, including, but not limited to, any claim for statutory benefits; and any claim arising under any common law principle or public policy, including, but
not limited to, all suits in tort or contract, such as wrongful termination, defamation, emotional distress, invasion of privacy or loss of consortium; provided, however, that this release shall not apply to (a) claims to enforce your rights
under this Agreement; (b) claims for vested benefits pursuant to ERISA; (c) claims with respect to your vested equity rights as of the Last Day of Employment; (d) claims to enforce the Company’s obligation to indemnify you to the
extent such indemnification obligations exist; and (e) claims or administrative charges which legally may not be waived. 
 You are waiving, however,
any right to monetary recovery or individual relief should any federal, state or local agency (including the Equal Employment Opportunity Commission) pursue any claim on your behalf arising out of or related to your employment with and/or separation
from employment with the Company; provided that nothing in this Agreement limits any right you may have to receive a whistleblower award or bounty for information provided to the Securities and Exchange Commission. 

You represent that you have not assigned any claim to any third party. You further acknowledge and represent that, except as expressly provided in this
Agreement, you have been paid all wages, bonuses, compensation, benefits and other amounts that any of the Releasees has ever owed to you. 

  
 5 













 7. Restrictive Covenants and Continuing Obligations 

(a) Restrictive Covenants Agreement. You acknowledge and agree that the terms of the Restrictive Covenants Agreement remain in full
force and effect, which, among other things, prohibits disclosure of the Company’s confidential information and contains a 12-month post-employment non-competition
and non-solicitation restriction. The terms of the Restrictive Covenants Agreement are incorporated by reference into this Agreement. 

(b) Return of Property. You acknowledge and agree that you are required to return all Company property to the Company pursuant to the
Restrictive Covenants Agreement upon the ending of your employment, including, without limitation, all files, letters, notes, memoranda, credit cards, reports, records, data, charts, quotations and proposals, specification sheets, educational
materials or other written, photographic or other tangible material containing proprietary information, including, without limitation your Company laptop. Notwithstanding this obligation, you may retain such Company property that is necessary, as
determined by the Board, for purposes of performing Services during the Consulting Period, provided that you promptly return all such Company property at the end of the Consulting Period. After returning all such Company property to the Company, you
must delete and finally purge any duplicates of files or documents that may contain Company information from any non-Company computer or other device that remains your property after the last day of the
Consulting Period. In the event that you discover that you continue to retain any such property, you must return it to the Company immediately. 

(c) Cooperation. You agree to cooperate reasonably with the Company (including its outside counsel) in connection with (i) the
contemplation, prosecution and defense of all phases of existing, past and future litigation about which the Company reasonably believes you may have knowledge or information; (ii) internal or external investigations related to matters that
occurred during your employment and about which the Company reasonably believes that you have relevant information and (iii) transitioning your duties (together “Cooperation Services”). You further agree to make yourself
available to provide Cooperation Services at mutually convenient times. The Company shall not utilize this section to require you to make yourself available to an extent that would unreasonably interfere with full-time employment or other business
responsibilities that you may have. The Company shall reimburse you for any reasonable travel expenses that you incur due to your performance of Cooperation Services, after receipt of appropriate documentation consistent with the Company’s
business expense reimbursement policy and the Company agrees to compensate you for your time in providing Cooperation Services performed after the Consulting Period at the rate of $400 per hour. 

  
 6 













 (d) Non-Disparagement.  

(i) You agree not to make, publish or communicate to any person or entity or in any public forum any disparaging or defamatory statements
(whether written, oral, through social or electronic media or otherwise) concerning any of the Releasees, any of their respective products or services or any of their respective current or former officers, directors, shareholders, employees or
agents. Your obligations under this Section 7(d)(i), together with your obligations under Sections 7(a) through (c), are collectively referred to as the “Continuing Obligations.” 

(ii) For its part, the Company agrees to instruct current members of the Board and current C-level
executives not to make, publish or communicate to any person or entity or in any public forum any disparaging or defamatory statements (whether written, oral, through social or electronic media or otherwise) concerning you or your work with the
Company, including not stating or implying that your retirement was anything other than a voluntary decision by you. In addition, C-level executives will instruct representatives of the Company’s public
relations and investor relations teams to not make any such disparaging or defamatory statements on behalf of the Company and, if C-level executives become aware that a representative has made disparaging or
defamatory statements regarding you on behalf of the Company they will take reasonable action to correct such statements. 
 (iii) For the
avoidance of doubt, nothing in this Agreement prohibits truthful testimony in a legal proceeding or prohibits you from communicating with a government agency. 

8. Communications Regarding Your Departure 

Promptly following the date of the public announcement regarding your planned retirement, the Company will issue a formal written internal
announcement about your planned retirement, with the content of such internal announcement to be mutually agreed upon by you and the Board (the “Company Announcement”). Until such time as the Company Announcement is made, you agree
that you will not (without the prior written approval of the Board) communicate about your planned retirement with anyone until after the Company Announcement has been made; provided that you may communicate with your tax advisor(s), attorney(s),
and spouse about your transition and departure before the Company Announcement; provided further that you first advise such persons not to reveal information about your transition and departure until the Company Announcement is made and each such
person agrees and provided further that you may inform the executive vice president and senior vice presidents within the Company as well as persons involved with preparations for public and internal communications provided that you first advise
such persons not to reveal information about your transition and departure until the Company Announcement is made and each such person agrees. Once the Company has made the Company Announcement, you agree to limit any communications regarding your
planned retirement to statements consistent with the Company Announcement. 

  
 7 













 9. Tax Treatment; Section 409A 

(a) The Company shall undertake to make deductions, withholdings and tax reports with respect to payments and benefits under this Agreement to
the extent that it reasonably and in good faith determines that it is required to make such deductions, withholdings and tax reports. Nothing in this Agreement shall be construed to require the Company to make any payments to compensate you for any
adverse tax effect associated with any payments or benefits or for any deduction or withholding from any payment or benefit. 
 (b) The
parties intend that payments under this Agreement will be exempt from or comply with Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”). To the extent that any provision of this Agreement is ambiguous as
to its exemption from or compliance with Section 409A of the Code, the provision shall be read in such a manner so that all payments hereunder are exempt from or comply with Section 409A of the Code. The Company makes no representation or
warranty and shall have no liability to you or any other person if any provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A of the Code but do not satisfy an exemption from, or the conditions
of, such Section. Each payment pursuant to this Agreement is intended to constitute a separate payment for purposes of Treasury Regulation Section 1.409A 2(b)(2). 

10. Time for Consideration; Effective Date. 

You acknowledge that you have knowingly and voluntarily entered into this Agreement and that the Company advises you to consult with an
attorney before signing this Agreement. You acknowledge that you have been given the opportunity, if you so desire, to consider this Agreement for twenty-one (21) days before executing it (the
“Consideration Period”). To accept this Agreement, you must return a signed, unmodified original or PDF copy of this Agreement so that it is received by the undersigned at or before the expiration of the Consideration Period. If you
sign this Agreement before the end of the Consideration Period, you acknowledge that such decision was entirely voluntary and that you had the opportunity to consider this Agreement for the entire Consideration Period. For the period of seven
(7) days from the date when you sign this Agreement, you have the right to revoke this Agreement by written notice to the undersigned, provided that such notice is delivered so that it is received at or before the expiration of the seven
(7) day revocation period. This Agreement shall not become effective or enforceable during the revocation period. This Agreement shall become effective on the first business day following the expiration of the revocation period (the
“Effective Date”). 
 11. Other Provisions 

(a) Absence of Reliance. In signing this Agreement, you are not relying upon any promises or representations made by anyone at or on
behalf of the Company. 
 (b) No Admission of Liability. This Agreement does not constitute an admission of liability or wrongdoing on
the part of the Company, the Company does not admit there has been any wrongdoing whatsoever against you, and the Company expressly denies that any wrongdoing has occurred. 

  
 8 













 (c) Entire Agreement. This Agreement, together with the Preserved Agreements,
constitutes the entire agreement between you and the Company and supersedes any previous agreements or understandings between you and the Company, including, without limitation, the Employment Agreement and the Severance Plan. 

(d) Severability. If any portion or provision of this Agreement (including, without limitation, any portion or provision of any section
of this Agreement) shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which it
is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law. 

(e) Relief. You agree that it would be difficult to measure any harm caused to the Company that might result from any breach by you of
any of the Continuing Obligations. You further agree that money damages would be an inadequate remedy for any breach of the Continuing Obligations. Accordingly, you agree that if you breach, or propose to breach, any portion of the Continuing
Obligations, the Company shall be entitled, in addition to all other remedies it may have, to an injunction or other appropriate equitable relief to restrain any such breach, without showing or proving any actual damage to the Company and without
the necessity of posting a bond, and to its costs of enforcement of the Continuing Obligations, including its reasonable attorney’s fees and expenses. 

(f) Governing Law; Interpretation. This Agreement shall be governed by the laws of the State of New Jersey, excluding the choice of law
rules thereof. In the event of any dispute, this Agreement is intended by the parties to be construed as a whole, to be interpreted in accordance with its fair meaning, and not to be construed strictly for or against either you or the Company or the
“drafter” of all or any portion of this Agreement. 
 (g) Jurisdiction. You and the Company hereby agree that the state and
federal courts in the State of New Jersey shall have the exclusive jurisdiction to consider any matters related to this Agreement, including without limitation any claim of a violation of this Agreement. With respect to any such court action, you
submit to the jurisdiction of such courts and you acknowledge that venue in such courts is proper. 
 (h) Waiver; Amendment. No waiver
of any provision of this Agreement shall be effective unless made in writing and signed by the waiving party. The failure of a party to require the performance of any term or obligation of this Agreement, or the waiver by a party of any breach of
this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach. This Agreement may not be modified or amended except in a writing signed by both you and the Chairman of the
Board. 

  
 9 













 (i) Counterparts. This Agreement may be executed in separate counterparts. When both
counterparts are signed, they shall be treated together as one and the same document. Electronic and pdf signatures shall be deemed to have the same legal effect as originals. 

[Signature page follows.] 

  
 10 













 Please indicate your agreement to the terms of this Agreement by signing and returning the original or a PDF
copy of this letter within the time period set forth above. 
  

			
	Sincerely,
	
	AMARIN CORPORATION PLC
		
	By:	 	 /s/ David Stack

	David Stack
	Chairman, Remuneration Committee

 This is a legal document. Your signature will commit you to its terms. By signing below, you acknowledge that you have
carefully read and fully understand all of the provisions of this Agreement and that you are knowingly and voluntarily entering into this Agreement. 
  

	
	 /s/ John F. Thero

	John F. Thero
	
	Date: April 12, 2021


  
 11